#United States #New York #Skin Cancer #Schweiger Dermatology #Mohs Surgery

Revolutionizing Dermatology Access

In a remarkable stride towards improving skin health, Schweiger Dermatology Group has announced unprecedented growth and opportunities for enhanced patient care in 2025. Recognized as one of the fastest-growing dermatology practices across the United States, they have made a commitment to providing patients with timely access to essential dermatology services, including same-week appointments and advanced skin cancer treatments.

A Year of Innovative Growth

Founded in 2010 by Dr. Eric Schweiger, a board-certified dermatologist, the practice has steadily gained momentum, culminating in an impressive 2.5 million patient visits in 2025 alone. Emphasizing a mission rooted in exceptional patient experience, the organization has successfully alleviated the burden of long wait times that often plague dermatology practices nationwide. With this innovative approach, patients can expect prompt evaluations and treatments, whether for medical, cosmetic, or surgical dermatology needs.

Prioritizing Early Skin Cancer Detection

As skin cancer continues to be the most prevalent type of cancer in the United States, the importance of early detection cannot be overstated. Dr. Schweiger noted, "Early detection saves lives, and our goal has always been to ensure that patients receive immediate attention and the highest standard of care." To fulfill this commitment, Schweiger Dermatology offers comprehensive full-body skin examinations designed to identify suspicious lesions at the earliest stages, enabling timely interventions that often lead to more favorable outcomes.

Leading the Way in Skin Cancer Treatments

Schweiger Dermatology's dedication to skin cancer treatment places them at the forefront of this critical healthcare area. In 2025 alone, the practice performed over 36,000 Mohs surgeries, making it one of the largest providers of this specialized treatment in the nation. Their comprehensive treatment offerings include:

• - Mohs Micrographic Surgery: Expertly conducted by fellowship-trained surgeons to ensure precise removal of skin cancer while preserving healthy tissue.
• - Surgical Excisions and Minimally Invasive Techniques: Tailored approaches that cater to individual patient needs, ensuring maximum comfort and efficacy.
• - Ongoing Screening and Long-Term Surveillance: Programs designed to keep patients safe and informed long after their initial treatment.

Dr. Glen Crawford, Chief Medical Officer, emphasizes the significance of quick access to dermatological care, stating, "Our commitment to expanding clinical capabilities and enhancing patient accessibility not only alleviates discomfort but also reduces the anxiety associated with waiting for critical diagnoses."

Patient-Centered Care: Quality and Trust

The foundation of Schweiger Dermatology's success lies in its commitment to a patient-centered model that prioritizes quality, trust, and convenience. With more than 70 board-certified dermatologists recognized as Castle Connolly Top Doctors, the practice consistently receives accolades for its clinical excellence. Patient satisfaction ratings remain exceptionally high, with over 90% of patients rating their experiences four or five stars.

This year, Schweiger Dermatology's achievements were not only acknowledged by their patients but also recognized in the 2025 Crain's Largest Private Companies in New York Area list, as well as marking their ninth consecutive year on the Inc. 5000 List for Fastest Growing Companies in America.

Conclusion

As one of the leading dermatology practices in the United States, Schweiger Dermatology Group is redefining the landscape of dermatology care with its focus on accessibility, quality, and patient satisfaction. With a modern approach to skin care, appointments often available within days, and a strong team committed to expert treatment, they are paving the way for a brighter future in dermatology. For more information and to schedule an appointment, visit schweigerderm.com.